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ABSTRACT
Propofol (2,6-diisopropylphenol) is a popular anesthetic agent for induction and anesthetic
maintenance. Propofol preparation is formulated as a lipid macroemulsion that is thermodynamically
unstable and degraded over time, causing the enlargement of droplet size. The degradation is faster
when propofol emulsion preparation package has been opened. This droplet enlargement results in
decreasing propofol releasing-rate and its concentration. The risk of embolism occurs whenever the
mean droplet size (MDS) exceeds Food and Drug Administration (FDA) limit (<0.45) and fat globule
population percentage >5 m (PFAT5) is <0.05%. In the daily practice, some propofol emulsion
preparation are often used although they are already opened and saved more than 24 hours. The aim
of this study was to evaluate the droplet size changes of propofol emulsion preparation during
storage. This was an observational study using cohort prospective design. The droplet size changes
of sixteen propofol preparation samples were evaluated before and after storage procedure for 6 and
24 hours in the refrigerator at the temperature of 4ºC. The droplet diameter was determined under a
light microscope. Mean droplet size before and after storage were calculated and analyzed by one
way analysis of variance (ANOVA), followed by Tukey’s post hoc test with 95% confidence interval
(p<0.05). The droplet diameter of propofol emulsion preparation increased significantly (p<0.05)
after storage procedure for 6 h (MDS value were: 247 ± 22 nm) and 24 h (278 ± 29 nm) compared
to before storage (225 ± 24 nm). The PFAT5 at each interval time was 0%. There was no color and
homogeneity changing at each interval time (n=16/100% each time interval). In conclusion, there is
a change of propofol emulsion preparation droplet size after storage procedure for 6 to 24 hours at
temperature of 4ºC compared to before storage.
ABSTRAK
Propofol (2,6-diisopropylphenol) merupakan obat anestesi yang populer baik untuk induksi maupun
pemeliharaan anestesi. Sediaan propofol dibuat dalam bentuk makroemulsi yang secara termodinamik
tidak stabil dan terurai selama waktu penyimpanan yang menyebabkan ukuran partikelnya membesar.
Peruraian emulsi propofol menjadi lebih cepat jika kemasan propofol telah dibuka. Pembesaran ukuran
partikel propofol berakibat penurunan kecepatan pelepasan propofol dan penurunan konsentrasi
propofol. Risiko emboli terjadi jika ukuran partikel melebihi batasan yang dipersyaratkan oleh FDA
yaitu rata-rata ukuran partikel <0,45 m dan fat globule population percentage >5 m (PFAT5)
<0.05%. Pada praktek sehari-hari sering dijumpai penggunaan emulsi propofol yang diambil dari
kemasan yang sudah dibuka dan disimpan lebih dari 24 jam. Tujuan penelitian ini adalah untuk
mengetahui perubahan ukuran partikel emulsi propofol sebelum dan setelah prosedur penyimpanan
selama 6 dan 24 jam. Penelitian ini adalah penelitian observasional dengan rancangan kohort prospektif.
Sebanyak 16 sampel sediaan propofol dievaluasi perubahan ukuran partikelnya sebelum dan setelah
penyimpanan selama 6 dan 24 jam dalam almari pendingan pada suhu 4oC. Diameter partikel diukur
di bawah mikroskop cahaya. Rerata ukuran tetesan (MDS) sebelum dan setelah dihitung dan dianalisis
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dengan analisis varian (ANAVA) satu jalan dilanjutkan dengan uji post hoc Tukey dengan taraf
kepercayaan 95% (p<0.05). Diameter partikel menjadi lebih besar secara nyata (p<0.05) setelah
prosedur penyimpanan selama 6 jam (nilai MDS sebesar 247 ± 22 nm) dan 24 jam (278 ± 29 nm)
dibandingkan dengan sebelum penyimpanan (225 ± 24 nm). Nilai PFAT5 tiap interval waktu sama
yaitu 0%. Secara makroskopis penampakan fisik, warna dan homogenitas sediaan propofol di setiap
interval waktu tidak berubah (masing-masing n=16/100%). Dapat disimpulkan, terjadi perubahan
ukuran partikel sediaan emulsi propofol setelah prosedur penyimpanan selama 6 dan 24 jam pada
temperatur 4oC dibandingkan sebelum penyimpanan.
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INTRODUCTION
Propofol (2,6-diisopropylphenol) is a
popular anesthetic agent for induction and
maintenance, because of its rapid onset, short
duration, and minimal side effects. Its use has
expanded from solely an anesthetic agent to a
sedative–hypnotic agent which is also used for
intensive care unit and in outpatient setting.1
Propofol is a potent lipophilic anesthetic which
was initially formulated in Cremophor El for
human use. Because of the occurrence of
Cremophor El anaphylaxis and improvements
in the quality of lipid emulsions, it was
ultimately brought to market as 1% propofol
formulated in 10% soybean oil emulsion,
lecithin (12 mg/mL), and glycerol (22.5 mg/mL)
(Diprivan® and Fresofol®).2,3
Propofol emulsion and other emulsions for
intravenous delivery are manufactured so that
the oil droplets average is 0.15–0.3m (150–
300 nm). These sizes are similar to naturally
occurring chylomicrons. In general, emulsions
with droplets of 0.1–100 m are known as
macroemulsions, whereas emulsions with
droplets of smaller size (< 0.1m, or 100 nm)
are known as microemulsions.4 Muller and
Harnisch5 studied the physico-chemical
characteristics of 8 emulsion preparations of
propofol available in the market produced by
several pharmaceutical industry which were
still on packages. The result showed that the
average diameter of droplet size of the emulsion
preparations of propofol varied from 205 to
259 nm. In addi tion, Ravenel le et al.2 also
examined the average droplet size emulsion
preparation of propofol Diprivan® 1% which
was still on the package with an average
diameter that was greater than the one observed
by Muller and Harnich (350 ± 50 nm).
The oil in water macroemulsion such as
propofol is thermodynamically unstable and will
degrade over time. The stability of emulsions
can be influenced and accelerated by the
presence of external factors such as mechanical
stress, temperature, light, pressure, micro-
organisms, pH, oxygen, carbon dioxide and the
ions of some electrolyte.6,7 Propofol emulsion
degradation occurs through the flocculation,
coalition, creaming and cracking processes.
Flocculation is caused by the merging of
droplets to one another, while coalescence
occurs when the surface of droplets has broken
and merged into a larger droplet size. If more
numerous flocculations happen, there will be
creaming and cracking appearing on the
emulsion surface.7
The droplet size becomes an important
parameter in determining the physical stability
of propofol emulsion because 1) the emulsion
degradation can affect the release of propofol
in vivo, as a result of surface area reduction
due to the enlargement of droplet size; 2) the
emulsion degradation can also cause variations
in the concentration of propofol in the emulsion
due to creaming volume; 3) it is important to
note that enlargement of the droplet size may
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cause an emboli when given intravenously, if
the droplet size is greater than 5-6m.7, 8
According to Driscoll9 and as required by
the Food and Drug Association (FDA), the
values of the mean droplet size (MDS) and the
percentage of large-diameter fat globules >5m
(PFAT5) of propofol should be <450 nm (0.45
m) and <0.05%, respectively. According to
Masaki et al.10 the time required for the change
of emulsion droplet until it is visible depends
on the initial droplet size according to Stokes
law, i.e. 3 minutes for the droplet size of 100
ìm, 5 hours for the droplet size 10 m, and 20
days for the droplet size of 1m. There has not
been any study yet that examines how long the
droplet size of propofol would be if it is more
than > 5m.
Propofol has the expired date of 2 years in
average after manufactured if it is stored as re-
commended. The recommended storage
temperature ranges between 2° to 25°C. It cannot
be stored at temperature over 25°C or freezing.
Moreover, it should not be exposed to sunlight
or ultraviolet rays directly. Propofol in its
manufacture is free from oxygen. Propofol
should be administered immediately after the
opening of the package (ampoules) for up to 6
hours (Fresofol®; Trivam®) or 12 hours
(Diprivan®). The time limit mentioned above
is related to the contamination of micro-
organisms in propofol that has been opened from
the package.11-14
On daily practice, it is often observed that
the propofol preparation has been opened from
the package, removed to a 10 cc syringe and
then stored in the refrigerator with temperature
of 4°C. Then, it is used again in the range of up
to 24 hours or even more, ignoring the
possibility of contamination, since the growth
of bacteria is slow in the refrigerator.
Consequently, the possibility of changes in
physical stability and in droplet size of the
emulsion of propofol preparation after storage
can be observed. Hence, it is essential to know
whether there has been a change in droplet size
in the propofol which is opened up to 6 hours
(time limit as recommended by the label) and
the one which is opened for 24 hours (the time
limit used in the reality of daily practice).
MATERIALS AND METHODS
This was an observational study with a
prospective cohort design in order to evaluate
the change of droplet size of emulsion
preparation of propofol before and after storage
procedures for 6 and 24 hours in 4oC. The
inclusion criteria for this study was a emulsion
preparation of propofol with 20 cc ampoule
packaging with the same batch number and
expired date and stored in accordance with the
recommended label. Sixteen samples of
emulsion preparation of propofol (Fresofol®)
from the same batch number (Batch No.
16DE0280 ED 31. 05. 11) were used in this
study.15 The exclusion criteria were any
macroscopic (visible) emulsion preparation of
propofol changes although the batch number and
expired date in accordance with the
predetermined and emulsion preparation of
propofol was allegedly damaged or had a
defective packaging. The drop out criteria were
the refrigerators no longer had a temperature of
4°C due to power supply failure, broken
refrigerator, and so on, not following the
procedures of working, and if the value of
baseline’s MDS was greater than 0.45 m
indicating that emulsion preparation of propofol
had been damaged before the study. The MDS
of emulsion preparation of propofol was used
as the primary outcome whereas the homogeneity
and the physical appearance of discoloration
were also observed visually and used as the
secondary outcome.
The measurement of the droplet diameter
of emulsion preparation of propofol was
performed by using an light microscope
Olympus CX 41 with Image plus DP 12 with a
magnification of 50X and 100X. At the 0 hour,
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the emulsion preparation of propofol was
opened from the package. Shortly, the physical
appearance was observed and the droplet
diameter and PFAT5 were calculated
simultaneously as base line data. Ten cc of
emulsion preparation contain of propofol was
removed to the 10 cc syringe that had been
labeled with sample number, date and hour and
then stored in a refrigerator with temperature
of 4°C. At the 6th and 24th hours after storage,
the physical appearance was re-observed and
droplet diameter and PFAT5 were recalculated.
Five hundreds droplets size were measured
their diameter for each sample at each time
interval in order to determine their MDS and
PFAT5 values.
All data were presented in the descriptive
statistics. The MDS and PFAT5 at 0 hour, 6th
and 24th hours after storage in 4oC were analyzed
with one-wayANOVAfollowed by Tukey’s test
to analyze the MDS and PFAT5 differences
between baseline and each time interval of the
storage. The p value <0.05 was considered as
statistically significant.15,16
RESULTS
Homogeneity and physical appearance of
discoloration of propofol preparation
The homogeneity and physical apperance
dicoloration of emulsion preparation of
propofol before (0 hour) and after storage
procedures for 6 and 24 hours in 4oC are
presented in TABLE 1. The homogeneity and
the color of the emulsion preparation of
propofol did not change in each time
observation.
Fat Globule Population Percentage >5m
and MDS of propofol preparation
The PFAT5 of the emulsion preparation of
propofol samples before (0 hour) and after
storage procedures for 6 and 24 hours in 4oC is
presented in TABLE 2. No sample droplet size
> 5 µm was observed in each time storage
procedures observation indicating that the
PFAT5s of the emulsion preparation of propofol
were 0 (%).
the emulsion preparation of propofol samples
tested was observed before and after storage
TABLE 2. The PFAT5 values of emulsion preparation of propofol
before (0 hour) and after after storage procedures for
6 and 24 hours in 4 oC
TABLE 1. Homogeneity and physical appearance of the emulsion of
emulsion preparation of propofol before (0 hour) and after
storage procedures for 6 and 24 hours in 4 oC
* Standard color: white milk
procedurs. The MDS before storge procedure
(0 hour) (225 ±24.2 nm) was significantly lower
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(p<0.01) than after storage procedure for 6 hour
(247±22.0 nm) and for 24 hour (278±28.8 nm).
Moreover, the MDS after storage procedure for
The differences of MDS of propofol
prepartaion emulsion before (0 hour) and after
storage procedures for 6 and 24 hours is
presented in TABLE 4. Statistical analysis
showed that there was significantly differences
of MDS between 0 and 6th hours (p=0.045), 0
and 24 th hours (p=0.001), and 6th and 24th hours
(p=0.040) observations (TABLE 4).
TABLE 4. The differences of MDS of emulsion preparation of propofol before
(0 hour) and after storage procedures for 6 and 24 hours in 4oC
DISCUSSION
Sixteen samples of emulsion preparation of
propofol were included in the study. Before
storage procedure or at 0 hour, all physical
appearance and homogeneity of samples were
the same (n=16; 100%) based on standardized
color and homo-geneity of the standards used.
The MDS value of samples was 225±24.2 nm
before storage procedure, whereas the PFAT5
value was 0%. It indicated that all samples at 0
6 hour was also significantly lower (p<0.01)
than for 24 hour (TABLE 3).
TABLE 3. Mean droplet size of emulsion preparation of propofol before (0 hour) and
after storage procedures for 6 and 24 hours in 4 oC
SD = Standard Deviation; ANOVA test; Fo 17.41; F crit 3.204; p<0.01*
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hours are in accordance with the criteria of FDA
(MDS < 450 nm and PFAT5 <0.05%). Morover,
the MDS value at 0 hour obtained in this study
was similar with the MDS value of others
emulsion preparation of propofol i.e. propofol
1% Fresenius® (MDS: 229±2.1 nm) and
propofol MCT/LCT emulsion generic (MDS:
212±1.2 nm) as reported by Muller and
Harnich.5 Therefore, the MDS and PFAT5 of
samples of this study at 0 hour can be used as
control group for samples after 6 and 24 hours
storage procedure.
Theoretically, as an emulsion preparation,
propofol will degrade over time, which can be
observed as droplet size change.7 This study
focused on propofol emulsion preparation
droplet size changes after 6 and 24 hours storage
procedures in 4ºC refrigerator. The result of this
study showed that the MDS of emulsion
preparation of propofol samples has changed
significantly (p<0.05) after 6 and 24 hours
storage procedure in oC (TABLE 3). This result
indicated that the emulsion preparation of
propofol which was already opened from its
packaging had a tendency to rapidly degrade.
The stability of emulsions can be influenced
and accelerated by the presence of external
factors such as mechanical stress, temperature,
light, pressure, microorganisms, pH, oxygen,
carbon dioxide and the ions of some
electrolyte. 6,7 The storage procedure in a
refrigerator with a temperature of 4oC, as
recommended in package insert i.e. in range of
temperature of 2-25oC, was performed in order
to minimize the influence of external factors.
However, if the emulsion preparation of
propofol has been already opened from the
ampoules and transferred in a syringe, the
storage procedure in the refrigerator can not
prevent the influence of external factors
especially oxygen to propofol in the syringe.
The propofol undergoes oxidative degradation
in the presence of oxygen.As reported by Ryoo14
lipid peroxidation can also lead to desta-
bilization of the emulsion preparation of
propofol through degradation of soybean oil
droplets contained in the preparation, although
its process is relatively slow. For this reason,
an emulsion preparation of propofol manu-
factured by pharmacetical industry should be
prepared in condition of free of oxygen that is
conducted by evacuating all the oxygen in the
ampoules and replacing it with hydrogen.6,14
After the storage procedure for 6 and 24
hours, change in the homogeneity and the color
of the emulsion preparation of propofol was
not observed macroscopically or visually
(TABLE 1). Baker et al.7 reported that the visual
change of an emulsion preparation of propofol
will be observed if the droplet size of the
emulsion preparation exceeds 50m.
However, microscopic obsevation showed
that the droples size of emulsion preparation of
propofol before (0 hour) was different with after
storage procedures for 6 and 24 hours in 4oC.
The largest droplet at 0 hour and after storage
procedure for 6 and 24 hours were 1.5, 2 and 3
ìm, respectively. Moreover, the MDS of
emulsion preparation of propofol increased
significantly (p < 0.05) and gradually after
storage procedure for 6 and 24 hours compared
to before storage procedure (0 hour) (TABEL 3
and 4). It was indicated that droplet size of the
emulsion preparation of propofol that was
already opened from the packaging has
significantly changed within 6 hour storage
procedure in 4oC. Although the droplet size of
emulsion preparation of propofol after 6 hour
storage changed, none of the droplet size
exceeded 5m. Therefore, the PFAT5 value at
three time observation were respectively 0%
(n=16; 100%) (TABLE 1).
The MDS and PFAT5 values are important
risk factors associated with embolism
incidence.7,8 This study showed that the change
of droplet size of emulsion preparation of
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propofol up to 24 hours was still below the
value required by the FDA (MDS-24 <450 nm
and PFAT5 <0.05%). The degradation of the
emulsion can affect the release of propofol in
vivo, as a result of reduced surface area due to
the enlargement of droplet size. Moreover, it
can also cause variations in the concentration
of propofol in volume emulsion.8
Masaki et al.10 studied the physicochemical
stability of combinations of propofol-lidocaine
mixtures frequently used in clinical practice. In
this study, various dose of lodocaine i.e. 5, 10,
20, or 40 mg were added to propofol pre-
paration. The result indicated that the addition
of 20 and 40 mg of lidocaine to propofol
preparation resulted in macroscopically color-
less layers at 3 and 24 h after preparation,
whereas, the mixture with 5 or 10 mg of
lidocaine was macroscopically stable.
Moreover, the addition of 40 mg lidocaine
decreased propofol concentrations significantly,
whereas, the mixture with 5, 10 or 20 mg of
lidocaine was unchanged compared with
baseline concentrations. Scanning electron
microscopy showed that droplets with diameters
> 5 µm first appeared after the addition of 40
mg of lidocaine to propofol preparation, and
the emulsion droplets were enlarged in a time-
and dose-dependent fashion. Depending on the
dose of lidocaine and the duration between its
preparation and administration, this combination
might pose the risk of pulmonary embolism.
Further study is needed to evaluate the implicat-
ion of the combinations of propofol-lidocaine
frequently used in clinical practice.
This study suggested that propofol pre-
paration should be used according to the
instruction in the packed insert that recommends
using propofol immediately and as soon as
possible after opened from the package. The
instruction in the packed insert suggests that
propofol preparation should be used not up to
6-12 hours after opened or stored. This study
showed that after 6 hours after storage
procedure at oC, enlargement of droplet size of
the emulsion preparation of propofol has been
observed although the droplet size was still
below the value required by the FDA.
CONCLUSION
The droplet size of emulsion preparation
of propofol enlarges significantly after the
storage procedures for 6 and 24 hours in
refrigerator with temperature of 4ºC. However,
the enlargement of the droplet size is still below
the value required by the FDA. Moreover,
macroscopical homogeneity and physical
apperance of the propofol preparation is stable
after the storage.
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